PFIZER, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.01 USD | -0.60% |
|
+0.72% | -2.71% |
| 05-12 | Pfizer and AstraZeneca announce new investments of nearly $1 billion in France | RE |
| 05-12 | Pfizer announces 500 million euros investment in France | RE |
Presenter SpeechTerence Flynn (Analysts)Okay. Great. Thanks, everybody, for joining us. I'm Te...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.01
USD
Average target price
31.94
USD
Spread / Average Target
+14.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.71% | 159B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Transcript : Pfizer Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 01